Unequal global access to inflammatory bowel disease (IBD) therapies creates profound health inequities. The increasing prevalence of IBD in Western countries, driven by high incidence rates and low ...
In 2022, Repsol agreed to sell a 25% stake in its upstream unit to EIG in a transaction that valued the division at $19bn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback